CryoPort, Inc. (CYRX): Price and Financial Metrics


CryoPort, Inc. (CYRX): $23.27

0.01 (+0.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CYRX POWR Grades


  • CYRX scores best on the Momentum dimension, with a Momentum rank ahead of 78.72% of US stocks.
  • CYRX's strongest trending metric is Value; it's been moving up over the last 179 days.
  • CYRX's current lowest rank is in the Value metric (where it is better than 1.86% of US stocks).

CYRX Stock Summary

  • The price/operating cash flow metric for Cryoport Inc is higher than 97.83% of stocks in our set with a positive cash flow.
  • Over the past twelve months, CYRX has reported earnings growth of 791.88%, putting it ahead of 97.26% of US stocks in our set.
  • Revenue growth over the past 12 months for Cryoport Inc comes in at 182.87%, a number that bests 95.56% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to CYRX, based on their financial statements, market capitalization, and price volatility, are LUNG, MNKD, KRMD, ACRX, and ZKIN.
  • CYRX's SEC filings can be seen here. And to visit Cryoport Inc's official web site, go to www.cryoport.com.

CYRX Valuation Summary

  • In comparison to the median Industrials stock, CYRX's price/sales ratio is 433.33% higher, now standing at 17.6.
  • Over the past 195 months, CYRX's price/sales ratio has gone down 552.8.
  • Over the past 195 months, CYRX's price/sales ratio has gone down 552.8.

Below are key valuation metrics over time for CYRX.

Stock Date P/S P/B P/E EV/EBIT
CYRX 2021-09-03 17.6 4.6 -38.0 -117.8
CYRX 2021-09-02 18.1 4.7 -39.1 -121.0
CYRX 2021-09-01 17.9 4.7 -38.5 -119.3
CYRX 2021-08-31 17.3 4.5 -37.3 -115.7
CYRX 2021-08-30 17.2 4.5 -37.0 -114.8
CYRX 2021-08-27 16.5 4.3 -35.6 -110.4

CYRX Growth Metrics

    Its 2 year price growth rate is now at 168.31%.
  • Its 5 year price growth rate is now at 974.61%.
  • Its 3 year net cashflow from operations growth rate is now at 60.7%.
Over the past 52 months, CYRX's revenue has gone up $211,746,854.

The table below shows CYRX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 222.608 8.126 -283.724
2021-09-30 214.5288 -4.201157 -75.50354
2021-06-30 169.0079 -17.92039 -78.39536
2021-03-31 122.2059 -21.91636 -76.80911
2020-12-31 78.696 -14.866 -75.029
2020-09-30 39.57723 -4.411822 -22.111

CYRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CYRX has a Quality Grade of D, ranking ahead of 10.08% of graded US stocks.
  • CYRX's asset turnover comes in at 0.284 -- ranking 160th of 682 Pharmaceutical Products stocks.
  • UTHR, INSM, and BDSI are the stocks whose asset turnover ratios are most correlated with CYRX.

The table below shows CYRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.284 0.435 -0.045
2021-06-30 0.276 0.449 -0.073
2021-03-31 0.260 0.455 -0.091
2020-12-31 0.263 0.462 -0.150
2020-09-30 0.203 0.540 -0.129
2020-06-30 0.229 0.525 -0.165

CYRX Price Target

For more insight on analysts targets of CYRX, see our CYRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $78.50 Average Broker Recommendation 1.28 (Strong Buy)

CYRX Stock Price Chart Interactive Chart >

Price chart for CYRX

CYRX Price/Volume Stats

Current price $23.27 52-week high $86.30
Prev. close $23.26 52-week low $19.82
Day low $22.08 Volume 409,600
Day high $23.90 Avg. volume 579,398
50-day MA $28.43 Dividend yield N/A
200-day MA $50.82 Market Cap 1.15B

CryoPort, Inc. (CYRX) Company Bio


CryoPort, Inc. provides cryogenic logistics solutions to the life sciences industry in the United States, Europe, Asia, and internationally. The company offers Cryoportal, a cloud-based logistics management software that automates the entry of orders, prepares customs documentation, and facilitates status and location monitoring of shipped orders while in transit; and CryoPort Express Shippers, which are cryogenic dry vapor shippers that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. The company was founded in 1999 and is based in Irvine, California.


CYRX Latest News Stream


Event/Time News Detail
Loading, please wait...

CYRX Latest Social Stream


Loading social stream, please wait...

View Full CYRX Social Stream

Latest CYRX News From Around the Web

Below are the latest news stories about Cryoport Inc that investors may wish to consider to help them evaluate CYRX as an investment opportunity.

Cryoport, Inc.'s (CYRX) CEO Jerrell Shelton on Q4 2021 Results - Earnings Call Transcript

Cryoport, Inc. (CYRX) Q4 2021 Earnings Conference Call February 24, 2022, 5:00 PM ET Company Participants Todd Fromer - President, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and...

SA Transcripts on Seeking Alpha | February 25, 2022

CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Cryoport Reports Fourth Quarter and Full Year 2021 Results

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced financial results for the three months and year ended December 31, 2021.

Yahoo | February 24, 2022

Here's Why CryoPort, Inc. (CYRX) is Poised for a Turnaround After Losing 22.8% in 4 Weeks

CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Yahoo | February 23, 2022

CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

Read More 'CYRX' Stories Here

CYRX Price Returns

1-mo -21.41%
3-mo -32.90%
6-mo -67.79%
1-year -55.56%
3-year 33.35%
5-year 580.41%
YTD -60.67%
2021 34.85%
2020 166.59%
2019 49.23%
2018 28.41%
2017 165.12%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9698 seconds.